Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 52,281 | N/A | N/A | -7,540 | -13,360 |
| Depreciation Amortization | 5,798 | N/A | N/A | 690 | 1,890 |
| Accounts receivable | -9,511 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 9,718 | N/A | N/A | N/A | N/A |
| Other Working Capital | 808 | N/A | N/A | -1,260 | -1,630 |
| Other Operating Activity | 15,391 | 0 | 0 | 3,580 | 4,760 |
| Operating Cash Flow | $74,485 | $N/A | $N/A | $-4,530 | $-8,340 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,803 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,645 | N/A | N/A | 10 | -390 |
| Purchase Sale Intangibles | -22,794 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -22,794 | 0 | 0 | 80 | -210 |
| Investing Cash Flow | $-28,243 | $N/A | $N/A | $90 | $-600 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -35,175 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,111 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -31,381 | 0 | 0 | -1,110 | 8,260 |
| Financing Cash Flow | $-63,445 | $N/A | $N/A | $-1,110 | $8,260 |
| Exchange Rate Effect | 1,510 | N/A | N/A | 0 | 0 |
| Beginning Cash Position | 89,948 | N/A | N/A | 8,460 | 9,140 |
| End Cash Position | 74,255 | N/A | N/A | 2,910 | 8,460 |
| Net Cash Flow | $-15,693 | $N/A | $N/A | $-5,550 | $-680 |
| Free Cash Flow | |||||
| Operating Cash Flow | 74,485 | N/A | N/A | -4,530 | -8,340 |
| Capital Expenditure | -2,645 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 71,839 | 0 | 0 | -4,530 | -8,340 |